e3343 - Age at diagnosis and bilateralization of unilateral retinoblastoma
 
Print this page
 
 
Topics
Retina - Clinical sciences - Oncology
Additional information
Oral presentation / Use of Powerpoint
Session information

This abstract has been assigned to session OOG 3 Pathology/Oncology.

This session will take place on Friday 7 October 2005 from 14:00 till 15:30 in room Vega.

 
Authors
Author 1HADJISTILIANOU T
Ophthalmology - Ocular Oncology Unit (Siena)
Author 2DE FRANCESCO S
Ophthalmology - Ocular Oncology Unit (Siena)
Author 3LORE C
Forensic Medicine (Siena)
Author 4MASTRANGELO D
Ophthalmology - Ocular Oncology Unit (Siena)
Author 5MENICACCI F
Ophthalmology (Siena)
Abstract
Purpose
to show that the most important risk factor of metachronous tumor development in the fellow eye in unilateral retinoblastoma, is an age at diagnosis of less than 12 months, while both the number of tumor foci at diagnosis and family history play only a marginal role, if any.
Methods
retrospective investigation on 167 unilateral retinoblastomas, diagnosed between 1980 and 2003.
Results
11 out of 167 patients (6.5%) developed tumors in the fellow eye after diagnosis of unilateral retinoblastoma. 12 out of 167 (7.1%) had a positive family history for the disease, but only three of them later developed tumors in the fellow eye. Multiple foci were detected in 23 out of 140 patients (27 cases not evaluated), but only one patient with multiple foci at diagnosis, later developed tumors in the other eye. Finally all cases (11) who developed metachronous bilateral retinoblastoma, had had a diagnosis of unilateral retinoblastoma before the age of 12 months, while none of those who were diagnosed after that age, later developed metachronous bilateral tumors.
Conclusions
an age at diagnosis of less than 12 month seems to be the only relevant risk factor for metachronous tumor development in the fellow eye in unilateral retinoblastoma, but, strangely enough, a positive family history does not seem to influence this outcome